兔寶寶(002043.SZ):產業基金對外投資企業法獅龍首發過會
格隆匯5月6日丨兔寶寶(002043.SZ)公佈,2020年4月30日,中國證券監督管理委員會第十八屆發行審核委員會召開2020年第61次發審委會議,德清兔寶寶金鼎資產管理合夥企業(有限合夥)(“兔寶寶產業基金”)參股公司法獅龍家居建材股份有限公司(“法獅龍”)首發申請獲通過。兔寶寶產業基金持有法獅龍228.63萬股,佔其發行前總股本的比例為2.36%。
根據相關規定,兔寶寶產業基金承諾自法獅龍完成增資擴股企業註冊變更登記之日(2018年12月26日)起三十六個月或自法獅龍發行股票上市之日起十二個月(孰晚日),不轉讓或委託他人管理於此次發行前所持有的法獅龍股份,也不由法獅龍回購上述股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.